fbpx

Type to search

Dr Reddy’s Plans ‘Business Continuity’ in Russia – ToI


Dr Reddy's
Dr Reddy's Laboratories said it was focused on employee safety and business continuity. Photo: Reuters.

 

Pharmaceutical major Dr Reddy’s Laboratories said it was focused on employee safety and business continuity in and around Russia, despite many western companies pulling out from the country in recent days, The Times of India reported.

No Indian company has publicly withdrawn from Russia and New Delhi has declined to condemn Moscow’s invasion of Ukraine, despite pressure from the US to do so. Many western companies have stopped sales of their best-known products in Russia.

Read the full report: The Times of India.

 

READ MORE:

 

China to Strengthen Pharma Anti-Monopoly Efforts

 

Asian Markets Rally As Pharma Chief Backs Vaccines On Omicron

 

Former Kangmei Pharmaceutical Boss Ma Xingtian Sent To Jail

 

 

George Russell

George Russell is a freelance writer and editor based in Hong Kong who has lived in Asia since 1996. His work has been published in the Financial Times, The Wall Street Journal, Bloomberg, New York Post, Variety, Forbes and the South China Morning Post.

logo

AF China Bond